Clinical Trials on Hematological Malignancies in Switzerland

Total 369 results

Thomas Zilli
University Hospital, Geneva

Recruiting

Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI

Haematological Malignancy

Switzerland
Novartis Pharmaceuticals

Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Hematological Malignancies

Germany, Switzerland, France
EMD Serono

Terminated

A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies

Haematological Malignancies

Italy, United States, Switzerland, Belgium, Germany
Luzerner Kantonsspital

Recruiting

Prevalence of FID and QoL in Patients With Oncological and With Haematological Malignancies

Functional Iron Deficiency

Switzerland
University Hospital Inselspital, Berne

Completed

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (LUNCH1)

Colitis | AML | Mucositis

Switzerland
Centre Hospitalier Universitaire Vaudois

Unknown

Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) (BIMI)

Hematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold Infections

Switzerland, Austria, Germany
Merck Sharp & Dohme LLC

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors | Hematologic Malignancies

United States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
University Hospital, Basel, Switzerland

Completed

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Febrile Neutropenia (FN)

Switzerland
Cellestia Biotech AG

Terminated

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Breast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALL

United States, Spain, Korea, Republic of, Germany, France, Switzerland
University Hospital, Basel, Switzerland
University of Basel; University Hospital, Zürich

Completed

Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation (PROVIVO)

Hematologic Neoplasms

Switzerland
Mundipharma Research Limited

Active, not recruiting

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Multiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell Lymphoma

France, United States, Netherlands, Spain, Switzerland, Germany, Italy
Theusinger Oliver M.

Completed

Anemia in Orthopedic Surgery - Determination of Hb

Anemia

Switzerland
University Hospital Inselspital, Berne

Completed

Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

Anemia

Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping

Transfusion Reaction

Switzerland
Novartis Pharmaceuticals

Terminated

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Advanced Malignancies

Taiwan, Netherlands, Italy, Korea, Republic of, Japan, United States, Switzerland, Canada, Singapore
University Hospital, Basel, Switzerland

Completed

Screening for Hemoglobinopathies in Pregnant Women

Hemoglobinopathies

Switzerland
University Hospital, Geneva

Completed

Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel

Acquired Platelet Disorder

Switzerland
University Hospital, Basel, Switzerland
Roche Pharma AG

Completed

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

Renal Anemia

Switzerland
Swiss Federal Institute of Technology
Columbia University

Completed

Iron Interventions and Non-transferrin-bound Iron (NTBI) in Women (NTBIwomen)

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From GDS Capsules

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
DSM Nutritional Products, Inc.

Completed

Absorption, Stable Isotope Appearance and Non-transferrin-bound Iron (NTBI) Profile From NaFeEDTA and Ferrous Sulphate (SIA)

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From Tef-injera in Women of Reproductive Age

Iron Deficiency

Switzerland
University Hospital, Basel, Switzerland

Completed

Pregnancy Outcome in Women With an Iron Deficiency in the First Trimester

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Bioavailability From Encapsulated Ferrous Sulphate

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From GDS Capsules II

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Measuring Erythrocyte Iron Incorporation From Different Dosing Regimens in Anemic Women

Iron Deficiency Anemia

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Switzerland
Swiss Federal Institute of Technology
Zurich University of Applied Sciences

Completed

Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability (Study 1) (Sustironable1)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Effect of Ovotransferrin and Lactoferrin on Iron Absorption From Ferrous Sulfate in Adult Women (OTf)

Iron-deficiency

Switzerland
Isabelle Herter-Aeberli
Burgerstein Vitamine

Completed

Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C (Fe_GOS_2)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology
Burgerstein Vitamine

Completed

Effect of Prebiotics on Iron Absorption in Women With Low Iron Stores (Fe_GOS_1)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Unknown

Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.

Iron-deficiency

Switzerland
Triemli Hospital
University of Zurich

Completed

Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm (SONALG)

Coagulation Disorder, Blood

Switzerland
Unilever R&D

Completed

Bioavailability of Iron From Savoury Food Product

Healthy | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From Rice Fortified With Ferric Pyrophosphate

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
Zurich University of Applied Sciences

Enrolling by invitation

Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability (Study 2) (Sustironable2)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Effect of Different Prebiotics on Iron Absorption From High Dose Iron Supplements

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Unknown

Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From Encapsulated Iron Sulphate in Microspheres

Iron-deficiency

Switzerland
Philipp Stein

Completed

Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX (ZnPP)

Iron-deficiency

Switzerland
University of Zurich

Completed

Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women

Iron Deficiency (Without Anemia)

Switzerland
Pierre-Alexandre Krayenbuehl

Completed

Plasma Hepcidin Response to Differently Dosed Iron Supplements

Iron Deficiency (Without Anemia)

Switzerland
Swiss Federal Institute of Technology

Completed

The Optimization of Bioavailability From Iron Supplements: Study 1

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Optimization of Bioavailability From Iron Supplements: Study 2

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
University Hospital, Zürich; ETH Zurich

Completed

Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
University Hospital Inselspital, Berne

Completed

Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy

Febrile Neutropenia | Pediatric Cancer | Oncology | Chemotherapy-induced Neutropenia

Switzerland
University Hospital, Geneva

Completed

Standardisation of Investigations of Mild Bleeding Disorders (MBD)

Hemorrhagic Disorders

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes

Switzerland
University Children's Hospital, Zurich

Completed

Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

Hemorrhage | Blood Coagulation Disorders

Switzerland
Oxagen Ltd

Completed

Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

Eosinophilic Esophagitis

Switzerland

Clinical Trials on Hematological Malignancies in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations